Hspg Modulation of Wnt5a Signal Transduction in Metastatic Melanoma Cells
نویسندگان
چکیده
Michael P. O’Connell, Jennifer L. Fiori, Emily K. Kershner, Brittany P. Frank, Fred E. Indig, Dennis D. Taub, Keith S. Hoek, and Ashani T. Weeraratna From the Laboratory of Immunology, the Laboratory of Clinical Investigation, the Confocal Imaging Unit, Research Resources Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224 and the Department of Dermatology, University Hospital of Zürich, 8091 Zürich, Switzerland Running Head: HSPGs modulate Wnt5A signaling in melanoma *Address for correspondence: Ashani T. Weeraratna, Ph.D., 251 Bayview Blvd, Suite 100, Rm08C226, Baltimore, MD 21224. Fax: (410) 558-8284, [email protected] #Present Address: St. Mary’s College of Maryland, St. Mary’s City, MD 20686
منابع مشابه
Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide
Cell surface heparan sulfate proteoglycan (HSPG) from metastatic mouse melanoma cells initiates cell adhesion to the synthetic peptide FN-C/H II, a heparin-binding peptide from the 33-kD A chain-derived fragment of fibronectin. Mouse melanoma cell adhesion to FN-C/H II was sensitive to soluble heparin and pretreatment of mouse melanoma cells with heparitinase. In contrast, cell adhesion to the ...
متن کاملWnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.
There are currently no effective therapies for metastatic melanoma and targeted immunotherapy results in the remission of only a very small percentage of tumors. In this study, we show that the noncanonical Wnt ligand, Wnt5A, can increase melanoma metastasis in vivo while down-regulating the expression of tumor-associated antigens important in eliciting CTL responses (e.g., MART-1, GP100, and t...
متن کاملHypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.
UNLABELLED An emerging concept in melanoma biology is that of dynamic, adaptive phenotype switching, where cells switch from a highly proliferative, poorly invasive phenotype to a highly invasive, less proliferative one. This switch may hold significant implications not just for metastasis, but also for therapy resistance. We demonstrate that phenotype switching and subsequent resistance can be...
متن کاملCYTOKINE AND GROWTH FACTOR MODULATION OF CELL CYCLE EVENTS IN HUMAN MELANOMA CELL LINES
Cytokines influence cell cycle events, which in some but not all instances can be associated with melanoma progression. Analysis of the G0/G 1 and S phase fractions of the cell cycle was used to assay the proliferative or inhibitory activity of cytokines against ten human melanoma cell lines, including pairs of cell lines derived from primary and metastatic tissue of individual patients. Cy...
متن کاملWNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
About half of all melanomas harbor a mutation that results in a constitutively active BRAF kinase mutant (BRAF(V600E/K)) that can be selectively inhibited by targeted BRAF inhibitors (BRAFis). While patients treated with BRAFis initially exhibit measurable clinical improvement, the majority of patients eventually develop drug resistance and relapse. Here, we observed marked elevation of WNT5A i...
متن کامل